• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[早期、手术切除的直径小于3厘米的非小细胞肺癌的死亡率:竞争风险分析]

[Mortality in early-stage, surgically resected non-small cell lung cancer less than 3 cm of size: Competing risk analysis].

作者信息

Jordá Aragón Carlos, Peñalver Cuesta Juan Carlos, Mancheño Franch Nuria, de Aguiar Quevedo Karol, Vera Sempere Francisco, Padilla Alarcón José

机构信息

Servicio de Cirugía Torácica, Hospital Universitario y Politécnico La Fe, Valencia, España.

Servicio de Cirugía Torácica, Instituto Valenciano de Oncología, Valencia, España.

出版信息

Med Clin (Barc). 2015 Sep 7;145(5):185-91. doi: 10.1016/j.medcli.2014.07.032. Epub 2014 Nov 26.

DOI:10.1016/j.medcli.2014.07.032
PMID:25433784
Abstract

BACKGROUND AND OBJECTIVE

Survival studies of non-small cell lung cancer (NSCLC) are usually based on the Kaplan-Meier method. However, other factors not covered by this method may modify the observation of the event of interest. There are models of cumulative incidence (CI), that take into account these competing risks, enabling more accurate survival estimates and evaluation of the risk of death from other causes. We aimed to evaluate these models in resected early-stage NSCLC patients.

PATIENTS AND METHOD

This study included 263 patients with resected NSCLC whose diameter was ≤ 3 cm without node involvement (N0). Demographic, clinical, morphopathological and surgical variables, TNM classification and long-term evolution were analysed. To analyse CI, death by another cause was considered to be competitive event. For the univariate analysis, Gray's method was used, while Fine and Gray's method was employed for the multivariate analysis.

RESULTS

Mortality by NSCLC was 19.4% at 5 years and 14.3% by another cause. Both curves crossed at 6.3 years, and probability of death by another cause became greater from this point. In multivariate analysis, cancer mortality was conditioned by visceral pleural invasion (VPI) (P=.001) and vascular invasion (P=.020), with age>50 years (P=.034), smoking (P=.009) and the Charlson index ≥ 2 (P=.000) being by no cancer.

CONCLUSIONS

By the method of CI, VPI and vascular invasion conditioned cancer death in NSCLC >3 cm, while non-tumor causes of long-term death were determined.

摘要

背景与目的

非小细胞肺癌(NSCLC)的生存研究通常基于Kaplan-Meier方法。然而,该方法未涵盖的其他因素可能会改变对感兴趣事件的观察。有累积发病率(CI)模型,其考虑了这些竞争风险,能够更准确地估计生存率并评估其他原因导致的死亡风险。我们旨在评估这些模型在接受手术切除的早期NSCLC患者中的应用。

患者与方法

本研究纳入了263例直径≤3 cm且无淋巴结转移(N0)的接受手术切除的NSCLC患者。分析了人口统计学、临床、形态病理学和手术变量、TNM分类以及长期演变情况。为分析CI,将其他原因导致的死亡视为竞争事件。单因素分析采用Gray方法,多因素分析采用Fine和Gray方法。

结果

NSCLC导致的5年死亡率为19.4%,其他原因导致的死亡率为14.3%。两条曲线在6.3年时相交,从这一点起,其他原因导致的死亡概率变得更高。在多因素分析中,癌症死亡率受脏层胸膜侵犯(VPI)(P = 0.001)和血管侵犯(P = 0.020)影响,而年龄>50岁(P = 0.034)、吸烟(P = 0.009)和Charlson指数≥2(P = 0.000)则与非癌症因素有关。

结论

通过CI方法,VPI和血管侵犯影响了直径>3 cm的NSCLC患者的癌症死亡,同时确定了长期死亡的非肿瘤原因。

相似文献

1
[Mortality in early-stage, surgically resected non-small cell lung cancer less than 3 cm of size: Competing risk analysis].[早期、手术切除的直径小于3厘米的非小细胞肺癌的死亡率:竞争风险分析]
Med Clin (Barc). 2015 Sep 7;145(5):185-91. doi: 10.1016/j.medcli.2014.07.032. Epub 2014 Nov 26.
2
Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.在肿瘤直径为 2cm 或以下且无区域淋巴结转移(pN0)的非小细胞肺癌患者中,脉管侵犯与脏层胸膜侵犯的预后影响比较。
J Surg Res. 2013 Nov;185(1):250-4. doi: 10.1016/j.jss.2013.05.104. Epub 2013 Jun 22.
3
Prognostic Factors in Non-Small Cell Lung Cancer Less Than 3 Centimeters: Actuarial Analysis, Accumulative Incidence and Risk Groups.非小细胞肺癌小于 3 厘米的预后因素:累积发生率和风险组的概率分析。
Arch Bronconeumol. 2015 Sep;51(9):431-9. doi: 10.1016/j.arbres.2014.11.014. Epub 2015 Jan 14.
4
[Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer].[脏层胸膜侵犯对Ⅰb期非小细胞肺癌预后的影响]
Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):368-71.
5
Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.列线图预测手术切除的 I 期非小细胞肺癌患者的特定原因死亡率:竞争风险分析。
Clin Lung Cancer. 2018 Mar;19(2):e195-e203. doi: 10.1016/j.cllc.2017.10.016. Epub 2017 Oct 28.
6
Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.淋巴血管侵犯可预测早期淋巴结阴性非小细胞肺癌患者的生存。
J Thorac Cardiovasc Surg. 2013 Oct;146(4):781-7. doi: 10.1016/j.jtcvs.2013.04.037. Epub 2013 Jun 15.
7
Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer.脏层胸膜侵犯对非小细胞肺癌患者生存的影响。
Lung Cancer. 2012 Nov;78(2):153-60. doi: 10.1016/j.lungcan.2012.08.004. Epub 2012 Sep 1.
8
Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.直径3厘米及以下的I期非小细胞肺癌切除术后的预后因素:脏层胸膜侵犯不影响总生存率和无病生存率。
J Thorac Cardiovasc Surg. 2007 Sep;134(3):638-43. doi: 10.1016/j.jtcvs.2007.04.059.
9
Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.临床ⅠA 期非小细胞肺癌亚肺叶切除术后局部区域复发的危险因素分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):372-8. doi: 10.1016/j.jtcvs.2013.02.057.
10
Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology.胸腔灌洗细胞学检查阳性的非小细胞肺癌患者的预后
Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):777-82. doi: 10.1093/icvts/ivv047. Epub 2015 Mar 11.

引用本文的文献

1
Diagnosis Value of Combined Detection of Serum SF, CEA and CRP in Non-Small Cell Lung Cancer.血清铁蛋白、癌胚抗原和C反应蛋白联合检测在非小细胞肺癌中的诊断价值
Cancer Manag Res. 2020 Sep 22;12:8813-8819. doi: 10.2147/CMAR.S268565. eCollection 2020.